Biologic medications such as omalizumab, mepolizumab, and dupilumab are used for severe asthma and have limited pregnancy safety data. Decisions about continuing or stopping biologics during pregnancy require careful, individualised specialist assessment. Dr. Dixit Kumar Thakur reviews each case at Pulmovista Clinics individually, weighing the risks of uncontrolled severe asthma against available evidence on biologic safety in pregnancy.
